Dermavir ICO Review & Details (DER)

In our Dermavir ICO Review (DER) you can find all the information you need to know about this Initial Coin Offering: Dermavir ICO Start & End, Dermavir ICO Price, Whitepaper, DER Team, Soft & Hard Cap, accepted currencies & more.

More Details About ICO

ICO NameDermavir
Start DateTBA
End DateTBA

Genetic Immunity is a US clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of therapeutic vaccines ("Immune Therapies") for the treatment of chronic viral infections (HIV, HPV), cancer and allergies. Our Immune Therapies are designed to intensify and boost specific immune response to modify or control these presently incurable diseases. We believe our products will allow people to live better, healthier and longer lives.

Chief Executive Officer
Chief Operations Officer
[custom-twitter-feeds screenname="DermavirICO"]
Price1.00 USD Sale10,000,000 Payment ModeETH
Minimum Investment0.1 ETH Distribution50% RaisedUnknown
Soft CapN/A Hard Cap10 000 000 DER

Buy Ledger Nano S